Arjuna Capital Laboratory Corp Of America Holdings Transaction History

Arjuna Capital

$347 Million
Q1 2024

A detailed history of Arjuna Capital transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Arjuna Capital holds 3,347 shares of LH stock, worth $705,882. This represents 0.21% of its overall portfolio holdings.

Number of Shares

3,347

Previous 2,414 38.65%

Holding current value

$705,882

Previous $548,000 33.39%

% of portfolio

0.21%

Previous 0.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$209.01 - $232.56 $195,006 - $216,978	933 Added 38.65%	3,347 $731,000
Q4 2023 Feb 08, 2024	BUY	$197.69 - $227.29 $117,625 - $135,237	595 Added 32.71%	2,414 $548,000
Q3 2023 Nov 09, 2023	BUY	$201.05 - $221.7 $11,459 - $12,636	57 Added 3.23%	1,819 $365,000
Q2 2023 Aug 09, 2023	BUY	$211.93 - $241.33 $12,927 - $14,721	61 Added 3.59%	1,762 $425,000
Q1 2023 May 15, 2023	BUY	$213.32 - $257.83 $31,144 - $37,643	146 Added 9.39%	1,701 $390,000

Q4 2022 Feb 06, 2023	SELL	$203.72 - $248.97 $823,436 - $1.01 Million	-4,042 Reduced 72.22%	1,555 $366,000
Q3 2022 Nov 01, 2022	BUY	$204.81 - $262.19 $33,384 - $42,736	163 Added 3.0%	5,597 $1.15 Million
Q2 2022 Jul 22, 2022	BUY	$213.86 - $277.87 $29,298 - $38,068	137 Added 2.59%	5,434 $1.27 Million
Q1 2022 May 12, 2022	BUY	$259.82 - $298.18 $119,517 - $137,162	460 Added 9.51%	5,297 $1.4 Million
Q4 2021 Feb 11, 2022	BUY	$271.6 - $314.21 $103,479 - $119,714	381 Added 8.55%	4,837 $1.52 Million
Q3 2021 Nov 08, 2021	BUY	$274.82 - $308.34 $167,640 - $188,087	610 Added 15.86%	4,456 $1.25 Million
Q2 2021 Aug 11, 2021	BUY	$251.87 - $278.14 $968,692 - $1.07 Million	3,846 New	3,846 $1.06 Million

Others Institutions Holding LH

# of Institutions

793

Shares Held

71.6M

Call Options Held

265K

Put Options Held

189K

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $18.9B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arjuna Capital, based on Form 13F filings with the SEC.

News

Stay updated on Arjuna Capital with notifications on news.

Account